chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At some point around 4:30-5 AM (12 hours after my  vaccine), I fainted after getting up to use the restroom. Before fainting it was watery mouth, cold sweating all over, ears starting to ring. I didn?t have a fever and I drink plenty of water. Every time I stood up to walk around for hours thereafter, the same feeling of getting ready to faint. Around 12-1 PM, I got a fever of 100.9 and started chilling and getting very tired. I took Tylenol and it subsided. Around 9 PM, I started getting a sharp, stabbing pain from under my left breast through to under my left shoulder blade. It was easily the worst pain I?ve ever experienced (un-sedated  childbirth included). Every time I would stand up abs give it a few minutes, it would subside. When I would lay back down again, it came on again. I took more Tylenol abs eventually was able to sleep. Woke up at 6 AM two days after the vaccine and felt pretty good; a little tired but that?s not necessarily uncommon for me.
About a week after receiving the vaccine I noticed new redness and tenderness/itching near the injection site.  The tenderness was similar to, but less severe, than the soreness experienced within the first 24 hours after injection.  I have not experienced a similar reaction to a vaccine (I had the influenza vaccine in 2020).  It appears to be resolving now - after about three days.  I've not sought any medical intervention.
Pt had initally started COVID series with Moderna and was given 2 nd dose with Pfizer. Pt was given the correct doses for age for vaccine type just had 2 different vaccines for primary series. Pt didn't have any adverse effects from 2 different vaccines.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 10:38 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 10:38 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 28.70. Concomitant products were not provided.  On 15-Apr-2021, Excursion time was 09 AM, temperature was 34, total doses given for the day was 188, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 06-Apr-2021, vial was moved to clinic on 15-Apr-2021. 18 vials were sent to clinic. Vaccine BUD date was 09-May-2021.  On 15-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 34, 10 AM: 36, 11 AM: 38, 12 AM: 39, 1PM: 43, 2 PM: 44, 3 PM: 44, 4 PM: 42, 5 PM: 42.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Pt recvd vax 18SEP92 & on 20SEP92 devel big red blotches on legs & arms; On 21SEP92 the blotches spread all over body except face; pt was seen by MD 22SEP92 who treated w/ Medrol & DPH;
Right deltoid area reddened, swollen, and tender. Instructed mom to give Children's Tylenol Q 4hours PRN and warm packs to area. Call if not resolved in 24 hours. Called mom 24 hours later- redness decreased to golf ball size, no discomfort. Mom using ice and Motrin. Pt did not miss any school.
Had my first shot in December 2020 and second shot January 2021. Now since 11/21/21 I have now been diagnosed with multiple sclerosis.
vertigo; dizziness; difficulty walking; This is a spontaneous report received from contactable reporter(s) (Nurse) from a sales representative.  A 60-year-old female patient (not pregnant) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 22Aug2023 as dose number unknown, single (Batch/Lot number: unknown), in arm for immunisation. The patient's relevant medical history included: "Plaque psoriasis" (unspecified if ongoing). The patient took concomitant medication. The following information was reported: GAIT DISTURBANCE (non-serious) with onset 23Aug2023, outcome "unknown", described as "difficulty walking"; DIZZINESS (non-serious) with onset 23Aug2023, outcome "unknown"; VERTIGO (non-serious) with onset 23Aug2023, outcome "unknown". It was unknown if therapeutic measures were taken as a result of vertigo, dizziness, gait disturbance. Additional information: The patient was also taking concomitant medication (unspecified drug) for plaque psoriasis.   The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
Her TSH was very elevated/TSH was 3 times out of normal range at 14.69/ on 01Mar2021 result was 14.16/on 04May2021 result was 6.6; This is a spontaneous report from a contactable nurse, the patient. This 78-year-old female patient reported for herself that she received the second dose of BNT162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, Lot number: Unknown) via an unspecified route on 13Feb2021 (at the age of 78-years-old) as a single dose for COVID-19 immunization. Medical history included diagnosis of Hashimoto's hypothyroidism last year (2020). Concomitant medication included levothyroxine sodium (SYNTHROID) since early 1980s for hypothyroidism; she is trying to regulate her dose of her medication. The patient previously received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot: unknown) via unspecified route on 23Jan2021 as a single dose for COVID-19 immunization. Patient reported that she had a routine lab test on 01Mar2021 which was abnormal. The other parameters for thyroid panel were within normal limits, but her TSH was very elevated. Her TSH was 3 times out of normal range at 14.69, with the range being 0.40-4.50.  When she got the first set of results, she thought there was a lab error and drew them again. TSH was redrawn on 11Mar2021 and the result was 14.16 and another lab draw on 04May2021 with the result of 6.6. She stated the only thing that is different, is that she had taken the vaccines. She also stated she is being followed by an endocrinologist. The outcome of the event was unknown.  The lot/batch number for the vaccine, BNT162b2, was not provided and will be requested during follow-up.
Patient said felt flushed after immunization. Has had high blood pressure and racing heart beat since immunization.
flu-like symptoms, fever, and weakness for a few days after the vaccines; flu-like symptoms, fever, and weakness for a few days after the vaccines; flu-like symptoms, fever, and weakness for a few days after the vaccines; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms, fever, and weakness for a few days after the vaccines), PYREXIA (flu-like symptoms, fever, and weakness for a few days after the vaccines) and ASTHENIA (flu-like symptoms, fever, and weakness for a few days after the vaccines) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A, 014M20A, 035C21A and 005M21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms, fever, and weakness for a few days after the vaccines), PYREXIA (flu-like symptoms, fever, and weakness for a few days after the vaccines) and ASTHENIA (flu-like symptoms, fever, and weakness for a few days after the vaccines). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms, fever, and weakness for a few days after the vaccines), PYREXIA (flu-like symptoms, fever, and weakness for a few days after the vaccines) and ASTHENIA (flu-like symptoms, fever, and weakness for a few days after the vaccines) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Patient reported having flu like symptoms, fever, and weakness for a few days after the vaccines.  Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-745568 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-745568:Same patient (Bivalent case)
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Severe, Systemic: Hypotension-Severe, Systemic: Nausea-Medium, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: after shot at 2:10pm complained of sweating, asked if "Am i going to dye" very anxious, nausea, lightheaded. had pt elevate legs and took bp1: at 2:15pm 96/55 pulse 68, bpt2: 21pm 117/80 pulse 93, complained of tingleness in lower extremities, 3rd bp: at 2:29pm 120/80 pulse 88,  had pt leave with friend at 2:34pm advised not to drive
rapid heart rate; tachycardia; This is a spontaneous report from a non-contactable consumer or other non hcp.A 16-years-old adolescent male patient received bnt162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: EW0172), via an unspecified route of administration, administered in right arm on 04May2021 12:00 (at the age of 16years old) as 2nd dose, single for COVID-19 immunization. The patient's Medical history included asthma, ongoing intermittent asthma (only during other upper respiratory illnesses) , respiratory disorder. Allergies were reported as No. The patient previously received bnt162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE,lotnumber:EP6955)via unspecified route of administration, In left arm, on 02Apr2021 at 11:15am as first dose, Single for COVID-19 Vaccination.The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19, since the vaccination.It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination.The patient's concomitant medications were not reported. On 05May2021 at 19:30 ,the patient experienced rapid heart rate and lasted all day Thursday, subsiding late Thursday night and periodically flaring up on Friday and Saturday. The patient underwent lab tests and procedures which included chest x-ray: clear on, electrocardiogram: mostly regular but confirmed tachycardia on. Therapeutic measures were taken as a result of rapid heart rate (heart rate increased), tachycardia (tachycardia).By Sunday 09May the tachycardia was apparently gone and so far as we can tell has not recurred. The case was reported as non-serious.The outcome for the events were recovering.
CHEST CONGESTION, COUGH, PRODUCTIVE COUGH, FLUID IN LUNGS. SEEN IN OUR OFFICE 12/18/2015. SYMPTOMS FOR 10+ DAYS.
This spontaneous report as received from a pharmacist via a company representative refers to a female patient of unknown age with no drug reactions or allergies. No medical history was provided. On 25-APR-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 injection (strength, dose, route and site of administration, lot# and expiry date unspecified). No concomitant medications were reported. On 26-APR-2015, the patient developed a red, hot area below the injection site. The patient sought medical attention, she came to pharmacy and received the treatment, as per pharmacist suggestion, the patient applied cold compresses to the area and took an unspecified antihistamine. No laboratory test were performed. The outcome of the event was unknown. The relatedness between the event and PNEUMOVAX 23 was not reported. Additional information is not expected as the reporting pharmacist did not grant permission to perform follow up contact.
Patient has NOT been seen in the office for side effects, but reports nose bleeds starting a few hours after receiving her first dose.
No further information provided, no additional AEs, no PQCs.; one dose of PEDVAXHIB from expired lot on 15APR2023 was administered on 26APR2023.; This spontaneous report was received from a certified medical assistant and refers to a 15-month-old male patient. No information regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided.  On 26-APR-2023, the patient was vaccinated with expired dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) 0.5 milliliter, once, lot # U003873 was confirmed to be valid, expiration date 15-APR-2023 for prophylaxis (route and site of administration were not reported). No additional adverse event was reported.
Information has been received from a registered nurse regarding an unknown age and gender patient. On 27-JUN-2013, the patient was vaccinated with an our of range dose of ZOSTAVAX (dose and route administration were not provided) (Lot number J001005, Exp. Date: 24-APR-2014). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
03/01/2017, Mild adverse reaction to vaccine component. Area was hot, swollen ET red, PT C/O itching and numbness that comes ET goes.
heart racing; patient may miss second dose of vaccine; This is a spontaneous report received from a contactable consumer. This consumer (patient's mother) reported for female patient that: A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. Medical history included anxiety from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient had allergic to shellfish, amoxicillin and nuts. It was reported that the caller refuses to give demographic information on herself or daughter. Caller was called on behalf of daughter. Caller daughter received first dose of vaccine in vaccination site. Caller would like to know if her daughter can get second dose of vaccine in name. Caller reports that her daughter has anxiety, allergies to shellfish, amoxicillin, nuts, and would like to know if her daughter anxiety could get worse after second dose. Caller reports that her daughter's heart was racing after first dose of vaccine. Caller would like to know if there are nuts and shellfish in vaccine. Caller reports that she heard on the news reports of heart inflammation or infection after someone gets the vaccine and would like to know more information about that. Caller would like to know how you would know if you are immunocompromised or what does that term mean. Caller would like to know how a person would know if they are allergic to ingredients in vaccine. Caller states that she heard that you could possibly get vaccine after 6 weeks. Caller requested more information on this. Caller was called because she was concerned about this vaccine, and she has some paperwork that she pulled up and has questions. Caller confirms she was called about the Pfizer COVID-19 Vaccine. Caller added, first of all, if somebody has the first vaccine and does it somewhere else can they do it. Caller clarified and asked can the second dose of the Pfizer COVID-19 vaccine be received if the first dose was given at a different location (patient may miss second dose of vaccine). Caller states she does not want to provide any additional details at this time regarding her or her daughter. Caller states she just has questions. The outcome of the events was unknown.  Information on Lot/Batch number has been requested.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Chills, fever with highest temp of 99.4, headache, Pt took Tylenol. Upset stomach body aches. pain at the site.
Ileocolic intussusception dx but not reduced by barium enema;required surgical reduction-no bowel resection;
Mini stroke (TIA) with slurred speech and facial droop or right cheek and lips, 219/97 BP on arrival at ER, testing and observation at ER for 36 hours, aspirin 81mg, atorvastatin 80mg, clopidogrel 75mg, BP 125/60 upon discharge from ER, speech normalized by time of discharge from ER, facial droop normalized within 3-4 days of discharge, continue taking aspirin and atorvastatin
Covid arm.  15th day after shot. Red and hot with darker spot where shot went in.   Fever aches and listlessness  on 16 th day.  Hot shower and in bed by 5pm
NONE.  This vaccine was given to a 16 year old and the minimum age for Moderna Covid-19 vaccine at this time is 18 years of age.
Patient received Pfizer for 6 months to  4yrs vaccine instead of Pfizer for 5yrs to11yrs old.  Patient parent notified.
Injection in L arm began to burn after completed night of 11/05/02 pt noted swollen area under arm. Swelling lasted 3-4 days. Treated with hot compress.
high BP, palpitations , dizziness, light headedness that lasted for 4-5 weeks after the 2 nd dose of vaccine on jan 7 2021
About 4 hrs post vax, pt cried very hard, couldn't breathe well and turned pale. She was taken to the ER, given a breathing treatment, and sent home. She was much better when she left the hospital. MD said the problem was from Prevnar.
Headache started around 10pm. Went to sleep. Woke up at 4:30am with bad muscle aches in head, neck, shoulders, arms, hips and legs. I had no appetite. I got heart palpitations, was dizzy and had the chills. I didn't think to check my temperature. I didn't start to feel normal again until Sunday evening.
8 days post injection After initial arm pain had subsided, I suddenly developed a large (circumference of tennis ball) red circle around injection site. It was warm, swollen, itchy, and painful. It spread overnight and continued to grow to size of baseball gradually moving down my arm. I was treated with a 7-day course of Doxycycline as it appeared to be cellulitis (though we have since read that it was more likely a delayed injection reaction.) Symptoms began to significantly subside 1-day after I began the Doxy (9 days after injection) and continued to improve until they were resolved several days later.
Tingling in area above breast and heart then  Heart rate and blood pressure increased. Metal taste in mout. Face and lips went numb.  Ears ringing loud. Dr at vaccination site. Stayed I was having an antihistamine reaction and she needed to cool my body and the blood to my brain down.   She iced my jugular on both sides of my neck for 20 minutes in vehicle with the window down and the ac on high.  It was quite cool.  Heart rate downed and Metal taste disappeared.  Face got some feeling back. Lips still were particularly numb.  She released me to go home after 3:45pm.   Tired, headache that night. Next day 4/2 tired, headache and   diarrhea all day. Ears ringing 4/3 slight headache , ears better. Diarrhea gone
Upon receiving the injection I was dizzy and a nurse brought me water. When I returned to my workplace, I got a migraine and felt mentally cloudy. The following day, I could barely lift my left arm and had some muscle soreness.  I was very fatigued for several days. Then, about a week after receiving the vaccine, I had severe muscle spasms in my back. They began in the thoracic region but at times the pain would travel to my lower back as well. These spasms continued for over a week. I sought relief by having a 60-minute massage, and the massage therapist informed me that she felt inflammation along the length of my spine, not in one localized area as with an injury, but along the erectors of my spine. The massage did help, but I still have chronic back pain, and have had migraines about once a week. I obtained a medical marijuana card and I now take CBD daily and use THC oral spray when I have a migraine or more severe back pain. I consulted with a neurologist who promptly dismissed my symptoms and said that it couldn't be from the vaccine, but there is absolutely nothing else that could have caused this. I am otherwise healthy and have had no injuries or events occur except for this vaccine.
Pt was given vaccine, advised to lay down for several min after shots. After approximately 10 min he walked to front of office and fainted at check out desk. He was carried back to room O2 sat 100% HR was 70. Patient was responsive and appropriate. Patient did hit the back of his head when he fell. No sign/symptoms of head injury.
pt recv vax 10SEP96 & 20SEP96 pt devel a diffuse rash on medial aspect of both forearms & on a small area of neck;pt exp some itching;it was noted that the rash did not appear varicella-like but looked like contact rash;